Finally, we show that a small Pyk2 inhibitor reduced melanoma migration without enhancing invadopodia activity contrarily to a small FAK inhibitor that reduced only the migration process but enhanced matrix degradation via relocation of FA component to invadopodia [24]. This evidence concerns the gene PTK2B and melanoma.